A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A),Catheterization & Cardiovascular Interventions

当前位置： X-MOL 学术 › Catheter. Cardiovasc. Interv. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A)
Catheterization & Cardiovascular Interventions ( IF 2.1 ) Pub Date : 2021-11-18 , DOI: 10.1002/ccd.30014
Sebastian Kufner ₁ , Himanshu Rai _{1,

2,

3} , Jens Wiebe ₁ , Felix Altevogt ₁ , Stylianos Pyxaras ₄ , Michael Joner _{1,

5} , Erion Xhepa ₁ , Salvatore Cassese ₁ , Roisin Colleran _{1,

2,

3} , Heribert Schunkert _{1,

5} , Bernhard Zrenner ₄ , Adnan Kastrati _{1,

5} , Robert A. Byrne _{1,

2,

3} ,

Affiliation

We investigated the clinical efficacy of a paclitaxel-coated balloon (PCB) with a novel matrix coating and reduced drug concentration in comparison with a widely used PCB with iopromide excipient.

中文翻译：